newsfilter
← Latest News
GlobeNewswire·

Aravive Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

HOUSTON, March 30, 2022 (GLOBE NEWSWIRE) -- Aravive, Inc. (NASDAQ:ARAV), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, announced today that it has entered into definitive agreements with a single h